AIMC Topic: Hypertriglyceridemia

Clear Filters Showing 1 to 6 of 6 articles

Machine learning-based prediction of LDL cholesterol: performance evaluation and validation.

PeerJ
OBJECTIVE: This study aimed to validate and optimize a machine learning algorithm for accurately predicting low-density lipoprotein cholesterol (LDL-C) levels, addressing limitations of traditional formulas, particularly in hypertriglyceridemia.

Development and validation of machine-learning models for predicting the risk of hypertriglyceridemia in critically ill patients receiving propofol sedation using retrospective data: a protocol.

BMJ open
INTRODUCTION: Propofol is a widely used sedative-hypnotic agent for critically ill patients requiring invasive mechanical ventilation (IMV). Despite its clinical benefits, propofol is associated with increased risks of hypertriglyceridemia. Early ide...

High triglycerides to HDL-cholesterol ratio is associated with insulin resistance in normal-weight healthy adults.

Diabetes & metabolic syndrome
AIM: To evaluate the association between high triglyceride/HDL-cholesterol (TG/HDL-C) ratio and insulin resistance (IR) or hyperinsulinemia after oral glucose tolerance test (OGTT) in normal-weight healthy adults.

Using recursive feature elimination in random forest to account for correlated variables in high dimensional data.

BMC genetics
BACKGROUND: Random forest (RF) is a machine-learning method that generally works well with high-dimensional problems and allows for nonlinear relationships between predictors; however, the presence of correlated predictors has been shown to impact it...

Triglycerides and glucose index as an insulin resistance marker in a sample of healthy adults.

Diabetes & metabolic syndrome
AIM: To assess the association between elevated triglycerides/glucose index (TGI) and insulin resistance (IR) or hyperinsulinemia after oral glucose tolerance test (OGTT) in a sample of healthy adults.

Machine Learning Reveals the Contribution of Lipoproteins to Liver Triglyceride Content and Inflammation.

The Journal of clinical endocrinology and metabolism
CONTEXT: Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently the most common chronic liver disease worldwide and is strongly associated with metabolic comorbidities, including dyslipidemia.